Roy Doumani - Director, Kite Pharma, Inc

As of October 5, 2017


Roy Doumani Net Worth

  • Net worth is estimated to be at least $3.48M
  • Owns at least 175,082 units of Kite Pharma, Inc stock
  • Sold an estimated value of $35.1M in the last 2 years at Kite Pharma, Inc

Roy Doumani Trading

  • Largest purchase of shares was 50,000 units , worth over $67.5K on March 2, 2017
  • Largest sale of shares was 18,800 units , worth over $1.4M on March 2, 2017
  • In total has made about 7 transactions over 2 years
  • Usually trades in June, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kite Pharma, Inc Insider Trading

  • The most recent transaction was 4,203 units sold on September 27, 2017 by Shawn Tomasello worth over $755.13K
  • In the last 2 years, insiders at Kite Pharma, Inc sold an estimated value of $864.82M and bought an estimated value of $20.6M
  • The most active traders are Cynthia Butitta, Chief Operating Officer,  Jeffrey Wiezorek, SVP Clinical Development,  and David Chang, EVP
  • Insider trading is most common in June, with the busiest year in 2017

Kite Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1